ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984

Fellowships In Japan Available Through NIH

October 13, 1995